Investigation of the Efficacy and Safety of JTT-751 in Non-dialysis CKD Patients (Double-blind Comparative Study)
Phase 3
- Conditions
- Chronic Kidney Disease
- Registration Number
- JPRN-jRCT2080221396
- Lead Sponsor
- JAPAN TABACCO INC.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Pre-dialysis patients with CKD stage 3-5
Exclusion Criteria
Patients with gastrointestinal diseases, such as peptic ulcer
Patients with advanced cardiac disease, or with hepatic dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change in serum P levels
- Secondary Outcome Measures
Name Time Method